TAVR Mortality Score (TVT Registry) Calculator
Clinical risk assessment
30-day mortality after transcatheter aortic valve replacement (TAVR)
The legacy calculator requested the following preprocedural variables. This form is provided for review only and does not store or submit patient data.
About the model
TVT Registry risk adjustment models are developed from registry data and are specific to their outcome definition, predictor set, and model version. They should not be recreated from an informal list of risk factors alone.
The published 30-day model described by Arnold and colleagues included a broader set of clinical and procedural factors and used hierarchical logistic regression. A later version incorporated health-status and gait-speed measures. The coefficients and baseline model specification are required to generate an individual predicted probability.
Legacy input variables
| Variable in original file | Unit / coding |
|---|---|
| Age | Years |
| Female sex | Yes / No |
| NYHA class IV | Yes / No |
| Serum creatinine | mg/dL |
| LVEF | % |
| Previous CABG | Yes / No |
| Peripheral vascular disease | Yes / No |
| Severe lung disease | Yes / No |
Clinical notes
- Do not interpret the old equation's output as a validated 30-day mortality probability.
- Use a validated and appropriately versioned institutional or registry risk model when estimating procedural risk.
- Risk scores support, but do not replace, Heart Team assessment and shared decision-making.
Reference for model verification
Arnold SV, et al. Inclusion of Functional Status Measures in the Risk Adjustment of 30-Day Mortality After Transcatheter Aortic Valve Replacement: A Report From the STS/ACC TVT Registry. JACC: Cardiovascular Interventions. 2018;11(6). DOI: 10.1016/j.jcin.2018.01.242.
Publicly available full text: PubMed Central.
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.